• Facebook Icon-01
  • Twitter Icon-01
  • Instagram Icon-01

Scleroderma Canada

41 King William St., Suite 203
Hamilton, Ontario L8R 1A2
Toll Free 1-866-279-0632
info@scleroderma.ca

www.scleroderma,ca

Scleroderma-Society-Canada-Societe-Canad

TREATMENT

OVERVIEW

Although there is currently no cure for scleroderma, intensive research efforts have resulted in significant advances in disease management. Treatments are focused on providing symptomatic relief and in minimizing the long term damage caused by collagen overproduction.

Due to the highly variable nature of the disease, treatment is often simultaneously managed by several specialists. Typically, primary disease management is provided by rheumatologists that specialize in the treatment of rheumatic diseases and musculoskeletal disorders.

Depending on disease progression, other specialists may become involved such as nephrologists (for kidneys), cardiologists (for the heart), gastroenterologists (for the digestive tract) or pulmonologists (for the lungs). Treatment plans are designed to target the specific problems unique to each scleroderma patient; as a result treatment can vary extensively over the course of the disease and from one individual to the next.

Additional professionals such as physical or occupational therapists, psychologists, nurse practitioners, patient educators, and social workers may also provide essential care. Dentists, orthodontists, and speech therapists can treat oral complications that arise from thickening of tissues in and around the mouth and face. Personalized treatment plans are best provided by health care professionals experienced in the care of people living with scleroderma.

Heart-01.png
Cosmetic-01.png

OUTLOOK

 

In most cases, localized scleroderma carries a good prognosis and patients have a normal life span. Most patients with limited CREST scleroderma can also expect a favourable outlook. Many internal organs may become affected over time, however disease progression tends to be slow.
 

Disease severity varies widely in systemic scleroderma, making it is difficult to predict future outcomes. Progression can be rapid and acute, quickly developing into a life threatening condition, or it can progress very slowly thereby offering better long term outcomes. The highest risk of disease progression is during the initial years of disease onset. During this critical period, patients run the highest risk of rapid progression and the development of serious complications, particularly if the lungs, heart, or kidneys are affected. Complete spontaneous improvement is very rare, however symptoms can be improved with medication and life style changes. Some medications are aimed at specific symptoms, while others are aimed at decreasing the activity of the immune system. Patient survival has improved a great deal over the past years due to advances in treatment.

 

SYMPTOM MANAGEMENT

 

Due to the highly individualized nature of the disease, symptom management plays a pivotal role in scleroderma treatment. Treatments are specific to the organ or organ systems involved and include both medical and non-medical approaches.

 

The ‘Scleroderma Patient Education Booklet’ developed by the director of the Johns Hopkins Scleroderma Centre - Dr. Fredrick Wigley - and behavioural psychologist Dr. Haythornthwaite, is an excellent resource and provides a thorough review of the causes, symptoms and treatment for many symptoms associated with scleroderma. An overview of symptom management is provided below, with links to the relevant chapters of the ‘Scleroderma Education Booklet’ where applicable.

 

 

 

 

 

 

 

 

For more information about living with scleroderma, read the following scleroderma handbook:

 

These informative brochures were developed by Drs. Maureen Mayes and Khanh Ho from the Scleroderma Foundation in conjunction with behavioral psychologist Dr. Jennifer Haythornthwaite and Johns Hopkins Scleroderma Center director Dr. Fredrick Wigley.

Kidneys-01.png
Gastrointestinal-01.png
Oral-01.png
Joint-01.png
Skin-01.png
Finger-01.png
Lungs-01.png
Psychological-01.png

MEDICAL GUIDE

Although at present there is no cure for scleroderma, several effective treatment options exist to help alleviate symptoms and slow down disease progression. Current medications are designed to treat scleroderma by targeting four key factors: inflammation, autoimmunity, vascular disease and tissue fibrosis. Patients must develop a keen understanding of prescribed medications and should understand the mechanism of action and how the drugs work to control disease symptoms from progressing. Patient knowledge is a powerful tool in reducing anxiety and increasing compliance, thereby resulting in a higher percentage of successful treatments.

The Scleroderma Medications Guide lists medications that are commonly prescribed by doctors to treat

patients with scleroderma. The list is provided for informational purposes only, and is not to be taken as an endorsement of any drug. Many of these drugs are prescribed by doctors, but have not been proven useful and should be used only with caution and supervision under the direct guidance of the prescribing doctor. It is important to consider that not every medication is appropriate for every scleroderma patient.